MLYS

David Malcom Rodman

Known title: Chief Medical OfficerCIK: 0001672659

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

Mineralys Presents Phase 3 Data, Receives Mixed Analyst Views. Mineralys Therapeutics presented new data from its pivotal Phase 3 Launch-HTN study at the American Heart Association Hypertension Scientific Sessions 2026. Following this update, UBS initiated coverage with a Neutral rating and a $29 price target, while HC Wainwright reiterated a Buy rating with a $56 target. The stock is currently trading near its support level, reflecting the divided analyst opinions on the company's outlook.

this person other insiders at MLYS

Transaction History

MLYS▲ Buy$35K
MLYS▼ Sell$59K
MLYS▲ Buy$6K
MLYS▼ Sell$11K
MLYS▼ Sell$169K
MLYS▲ Buy$36K
MLYS▲ Buy$59K
MLYS▲ Buy$7K
MLYS▼ Sell$388K
MLYS▲ Buy$35K
MLYS▼ Sell$66K
MLYS▲ Buy$6K
MLYS▲ Buy$59K
MLYS▼ Sell$115K
MLYS▲ Buy$36K
MLYS▼ Sell$235K
MLYS▲ Buy$7K
MLYS▼ Sell$152K
MLYS▲ Buy$35K
MLYS▼ Sell$54K
MLYS▲ Buy$6K
MLYS▼ Sell$11K
MLYS▲ Buy$36K
MLYS▲ Buy$59K
MLYS▼ Sell$402K
MLYS▲ Buy$7K
MLYS▼ Sell$186K
MLYS▲ Buy$35K
MLYS▼ Sell$65K
MLYS▲ Buy$6K
MLYS▼ Sell$13K
MLYS▼ Sell$176K
MLYS▲ Buy$7K
MLYS▲ Buy$36K
MLYS▲ Buy$59K
MLYS▼ Sell$373K
MLYS▲ Buy$35K
MLYS▼ Sell$59K
MLYS▲ Buy$6K
MLYS▼ Sell$11K
MLYS▲ Buy$36K
MLYS▲ Buy$59K
MLYS▼ Sell$278K
MLYS▼ Sell$84K
MLYS▼ Sell$7K
MLYS▼ Sell$174K
MLYS▲ Buy$7K
MLYS▲ Buy$35K
MLYS▼ Sell$58K
MLYS▲ Buy$0
MLYS▲ Buy$6K
MLYS▼ Sell$12K
MLYS▲ Buy$36K
MLYS▼ Sell$97K
MLYS▲ Buy$59K
MLYS▼ Sell$114K
MLYS▼ Sell$175K
MLYS▲ Buy$7K
MLYS▼ Sell$169K
MLYS▼ Sell$15K
MLYS▲ Buy$35K
MLYS▼ Sell$66K
MLYS▲ Buy$6K
MLYS▼ Sell$13K
MLYS▼ Sell$371K
MLYS▲ Buy$59K
MLYS▼ Sell$252K
MLYS▲ Buy$36K
MLYS▲ Buy$7K
MLYS▼ Sell$205K
MLYS▲ Buy$35K
MLYS▼ Sell$72K
MLYS▲ Buy$30K
MLYS▲ Buy$156K
MLYS▲ Buy$266K
MLYS▲ Buy$858K
MLYS▲ Buy$961K
MLYS▼ Sell$4.8M
MLYS▼ Sell$1.9M
MLYS▲ Buy$11K
MLYS▲ Buy$56K
MLYS▲ Buy$95K
MLYS▲ Buy$323K
MLYS▲ Buy$345K
MLYS▼ Sell$2.5M
MLYS▼ Sell$446K
MLYS▼ Sell$334K
MLYS▼ Sell$75K
MLYS▼ Sell$147K
MLYS▲ Buy$7K
MLYS▼ Sell$166K
MLYS▲ Buy$7K
MLYS▼ Sell$166K
MLYS▲ Buy$7K
MLYS▼ Sell$174K
MLYS▲ Buy$7K
MLYS▲ Buy$7K
MLYS▼ Sell$125K
MLYS▼ Sell$41K
MLYS▲ Buy$2K
MLYS▼ Sell$45K
MLYS▼ Sell$376K
MLYS▼ Sell$459K
MLYS▲ Buy$7K
MLYS▲ Buy$7K
MLYS▲ Buy$3K
MLYS▲ Buy$7K
MLYS▲ Buy$3K
MLYS▲ Buy$5K
MLYS▲ Buy$3K
MLYS▼ Sell$75K
MLYS▲ Buy$28K
MLYS▼ Sell$383K
MLYS▲ Buy$6K
MLYS▲ Buy$3K
MLYS▲ Buy$7K
MLYS▲ Buy$3K
MLYS▲ Buy$3K
MLYS▲ Buy$7K
MLYS▼ Sell$8K
MLYS▲ Buy$567
MLYS▲ Buy$7K
MLYS▲ Buy$3K
MLYS▲ Buy$7K
MLYS▲ Buy$3K
MLYS▲ Buy$3K
MLYS▲ Buy$7K
MLYS▲ Buy$108
MLYS▼ Sell$2K
MLYS▲ Buy$7K
MLYS▲ Buy$3K
MLYS▲ Buy$7K
MLYS▲ Buy$3K
MLYS▲ Buy$7K
MLYS▲ Buy$3K
MLYS▲ Buy$7K
MLYS▲ Buy$3K
MLYS▲ Buy$3K
MLYS▲ Buy$3K
MLYS▲ Buy$5K
MLYS▲ Buy$44K
MLYS▼ Sell$1.0M
MLYS▲ Buy$82K
MLYS▼ Sell$976K
MLYS▲ Buy$40K
MLYS▼ Sell$982K

We use analytics to understand how market-wall is used. No personal data is sold.